RichardLDemingMD

Radiation Oncology • Des Moines, IA

Medical Director Mercy Cancer Center

Join to view full profile

Dr. Deming is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Deming's full profile

Already have an account?

Office
411 Laurel St
Suite C100
Des Moines, IA 50314
Phone+1 515-643-8780
Is this information wrong?

Education & Training

University of California (San Francisco)Residency, Radiation Oncology, 1986 - 1987
Naval Medical Center (San Diego)Residency, Radiation Oncology, 1984 - 1986
Naval Medical Center (San Diego)Internship, Internal Medicine, 1980 - 1981
Creighton University School of MedicineClass of 1980

Certifications & Licensure

IA State Medical License 1989 - 2025
CA State Medical License 1985 - 2024
American Board of Radiology Radiation Oncology

Clinical Trials

Temozolomide and Radiation Therapy in Treating Patients With Stage IV Malignant Melanoma With Measurable and Unresectable Cancer of the Central Nervous System Start of enrollment: 2004 Jan 01
Terminated
Phase 2
Neoadjuvant Celecoxib and Capecitabine Combined With Pelvic Irradiation in Treating Patients With Stage II or Stage III Adenocarcinoma (Cancer) of the Rectum Start of enrollment: 2004 Dec 01
Terminated
Phase 2
Stereotactic Radiation Therapy With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases Start of enrollment: 2006 Jul 01
Completed
Phase 3
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Start of enrollment: 2011 Jan 24
Active, not recruiting
Phase 3
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors Start of enrollment: 2018 Oct 26
Active, not recruiting
Phase 3
Gemcitabine and Cisplatin Without Cystectomy for Patients With Muscle Invasive Bladder Urothelial Cancer and Select Genetic Alterations Start of enrollment: 2018 Aug 01
Recruiting
Phase 2
Targeted Treatment for ALK Positive Patients Who Have Previously Been Treated for Non-squamous Non-small Cell Lung Cancer Start of enrollment: 2019 Jul 25
Active, not recruiting
Phase 2
Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers Start of enrollment: 2019 Feb 07
Active, not recruiting
Phase 3
Testing the Addition of a New Immunotherapy Drug, Atezolizumab (MPDL3280A), to the Usual Chemoradiation (CRT) Therapy Treatment for Limited Stage Small Cell Lung Cancer (LS-SCLC) Start of enrollment: 2019 Jul 26
Active, not recruiting
Phase 3
Treatment Effects on Development of Chemotherapy-Induced Peripheral Neuropathy in Patients With Cancer Start of enrollment: 2019 May 14
Active, not recruiting
Effect of Treatment on Work Experience in Patients With Stage I-III Prostate Cancer Start of enrollment: 2019 Jul 19
Active, not recruiting
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer Start of enrollment: 2020 Jun 17
Recruiting
Phase 2, Phase 3
Testing the Addition of the Drug Atezolizumab to the Usual Radiation Treatment for Patients With Early Non-small Cell Lung Cancer Start of enrollment: 2020 Aug 13
Recruiting
Phase 3
Serum-derived Bovine Immunoglobulin Effect on Mucositis Start of enrollment: 2020 Jan 17
Terminated
Phase 2
Testing Maintenance Therapy for Small Cell Lung Cancer in Patients With SLFN11 Positive Biomarker Start of enrollment: 2020 Jul 20
Active, not recruiting
Phase 2
Testing the Addition of an Anti-cancer Immune Therapy Drug (Nivolumab) to the Usual Chemotherapy Treatment (Cisplatin or Carboplatin With Gemcitabine) for Recurrent or Metastatic Nasopharyngeal Cancer Start of enrollment: 2020 Dec 09
Terminated
Phase 3
Join now to see all

Publications & Presentations

PubMed

Long-term Outcomes of Chemoradiation for Muscle-invasive Bladder Cancer in Noncystectomy Candidates. Final Results of NRG Oncology RTOG 0524-A Phase 1/2 Trial of Pacli...
Douglas M Dahl, Theodore G Karrison, M Dror Michaelson, Huong T Pham, Chin-Lee Wu, Gregory P Swanson, William U Shipley, Jacqueline Vuky, R Jeffrey Lee, Anthony L Ziet...> ;European Urology Oncology. 2024 Feb 1
54 citations
Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for Limited Brain Metastases: A Secondary Analysis of the North Central Cancer Treatment Group ...
Thomas M. Churilla, Karla V. Ballman, Paul D. Brown, Erin Twohy, Kurt A. Jaeckle, Elana Farace, Jane H. Cerhan, S. Keith Anderson, Xiomara W. Carrero, Yolanda I. Garce...> ;International Journal of Radiation Oncology, Biology, Physics. 2017 Dec 1
14 citations
Results of NCCTG N0275 (Alliance) - a phase II trial evaluating resection followed by adjuvant radiation therapy for patients with desmoplastic melanoma
William G. Rule, Jacob B. Allred, Barbara A. Pockaj, Svetomir N. Markovic, David J. DiCaudo, Lori A. Erickson, Richard L. Deming, Steven E. Schild> ;Cancer Medicine. 2016 Aug 1
8 citations
Assessment of patient-reported measures of bowel function before and after pelvic radiotherapy: an ancillary study of the North Central Cancer Treatment Group study N0...
Pamela J. Atherton, Michele Y. Halyard, Jeff A. Sloan, Robert C. Miller, Richard L. Deming, T. H. Patricia Tai, Kathy J. Stien, James A. Martenson> ;Supportive Care in Cancer. 2013 Apr 1
11 citations
Sequential injection spectrophotometric determination of tetracycline antibiotics in pharmaceutical preparations and their residues in honey and milk samples using ytt...
Wish Thanasarakhan, Senee Kruanetr, Richard L. Deming, Boonsom Liawruangrath, Sunantha Wangkarn, Saisunee Liawruangrath> ;Talanta. 2011 Jun 15
91 citations
Mometasone furoate effect on acute skin toxicity in breast cancer patients receiving radiotherapy: a phase III double-blind, randomized trial from the North Central Ca...
Robert C. Miller, David Schwartz, Jeff A. Sloan, Patricia C. Griffin, Richard L. Deming, Jon C. Anders, Thomas J. Stoffel, Robert E. Haselow, Paul L. Schaefer, James D...> ;International Journal of Radiation Oncology, Biology, Physics. 2011 Apr 1
15 citations
Brain Metastases From Melanoma: Is There a Role for Concurrent Temozolomide in Addition to Whole Brain Radiation Therapy?
Steven E. Schild, Deepti Behl, Svetomir N. Markovic, Paul D. Brown, Jonathan R. Sande, Richard L. Deming, Kendrith M. Rowland, James D. Bearden> ;American Journal of Clinical Oncology. 2010 Dec 1
46 citations
Comparison of provider-assessed and patient-reported outcome measures of acute skin toxicity during a Phase III trial of mometasone cream versus placebo during breast ...
Michelle A. Neben-Wittich, Pamela J. Atherton, David Schwartz, Jeff A. Sloan, Patricia C. Griffin, Richard L. Deming, Jon C. Anders, Charles L. Loprinzi, Kelli N. Burg...> ;International Journal of Radiation Oncology, Biology, Physics. 2009 Nov 1
88 citations
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials
Nathan R. Foster, Sumithra J. Mandrekar, Steven E. Schild, Garth D. Nelson, Kendrith M. Rowland, Richard L. Deming, Timothy F. Kozelsky, Randolph S. Marks, James R. Je...> ;Cancer. 2009 Jun 15
47 citations
Cloud-point extraction and reversed-phase high-performance liquid chromatography for the determination of carbamate insecticide residues in fruits.
Apichai Santalad, Supalax Srijaranai, Rodjana Burakham, Jeremy D. Glennon, Richard L. Deming> ;Analytical and Bioanalytical Chemistry. 2009 Feb 26
22 citations
Phase III, Double-Blind Study of Depot Octreotide Versus Placebo in the Prevention of Acute Diarrhea in Patients Receiving Pelvic Radiation Therapy: Results of North C...
James A. Martenson, Michele Y. Halyard, Jeff A. Sloan, Gary M. Proulx, Robert C. Miller, Richard L. Deming, Stephen J. Dick, Harold A. Johnson, T. H. Patricia Tai, Ang...> ;Journal of Clinical Oncology. 2008 Nov 10
40 citations
The value of combined-modality therapy in elderly patients with stage III nonsmall cell lung cancer.
Steven E. Schild, Sumithra J. Mandrekar, Aminah Jatoi, William L. McGinnis, P. J. Stella, Richard L. Deming, James R. Jett, Yolanda I. Garces, Katie L. Allen, Alex A. ...> ;Cancer. 2007 Jul 15
44 citations
Results of combined-modality therapy for limited-stage small cell lung carcinoma in the elderly.
Steven E. Schild, Philip J. Stella, Burke J. Brooks, Sumithra J. Mandrekar, James A. Bonner, William L. McGinnis, James A. Mailliard, James E. Krook, Richard L. Deming...> ;Cancer. 2005 Jun 1
19 citations
Theoretical study of hydrogen-bonded complexes of chlorophenols with water or ammonia: Correlations and predictions of pKa values.
Jun Han, Richard L. Deming, Fu-Ming Tao> ;The Journal of Physical Chemistry. A. 2005 Jan 25
6 citations
Enhanced sensitivity and selectivity in the detection of polycyclic aromatic hydrocarbons using sequential simplex optimization, the addition of an organic modifier an...
Nattawan Kuppithayanant, Mongkon Rayanakorn, Sugunya Wongpornchai, Tippawan Prapamontol, Richard L. Deming> ;Talanta. 2003 Dec 23
6 citations
Simultaneous determination of nitrite and nitrate ions in culture media by ion interaction chromatography.
Jirasak Threeprom, Surasak Watanesk, Ruangsri Watanesk, Pairoje Kijjanapanich, Pairote Wiriyacharee, Richard L. Deming> ;Analytical Sciences. 2002 Aug 1
3 citations
Use of the simplex method to optimize the mobile phase for the micellar chromatographic separation of inorganic anions
Supalax Srijaranai, Rodjana Burakham, Tipwan Khammeng, Richard L. Deming> ;Analytical and Bioanalytical Chemistry. 2002 Jul 24
5 citations
Simplex optimization of ion-pair reversed-phase high performance liquid chromatographic analysis of some heavy metals.
Supalax Srijaranai, Rodjana Burakham, Richard L. Deming, Tipwan Khammeng> ;Talanta. 2002 Mar 11
53 citations
Olsalazine is contraindicated during pelvic radiation therapy: Results of a double-blind, randomized clinical trial
James A. Martenson, Glenn Hyland, Charles G. Moertel, James A. Mailliard, Judith R. O'Fallon, Roger T. Collins, Roscoe F. Morton, Hamed H. Tewfik, Randy L. Moore, Albe...> ;International Journal of Radiation Oncology, Biology, Physics. 1996 May 1
23 citations
Pilot study of human recombinant interferon gamma and accelerated hyperfractionated thoracic radiation therapy in patients with unresectable stage IIIA/B nonsmall cell...
Edward G Shaw, Richard L Deming, Edward T Creagan, Suresh G. Nair Md, John Q. Su, Ralph Levitt, Preston D Steen, Martin Wiesenfeld, James A. Mailliard> ;International Journal of Radiation Oncology, Biology, Physics. 1995 Feb 15
Follow-up of Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.
Deming, R. L., Constine, L. S., Elman, A. J., Hoppe, R. T., Mauch, P. M., Dosoretz, D. E., Pistenmaa, D. A., Prosnitz, L. R., Wolkov, H. B., Yahalom, J., Chauvenet, A....> ;Radiology. 2000 Jun
Stage III and IV Hodgkin's disease treatment guidelines. American College of Radiology. ACR Appropriateness Criteria.
Prosnitz, L. R., Connors, J. M., Deming, R. L., Yahalom, J., Mauch, P. M., Constine, L. S., Dosoretz, D. E., Elman, A. J., Hoppe, R. T., Pistenmaa, D. A., Wolkov, H. B...> ;Radiology. 2000 Jun
Pediatric Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.
Constine, L. S., Wolkov, H. B., Yahalom, J., Mauch, P. M., Deming, R. L., Dosoretz, D. E., Elman, A. J., Hoppe, R. T., Pistenmaa, D. A., Prosnitz, L. R., Chauvenet, A....> ;Radiology. 2000 Jun
Staging evaluation for patients with Hodgkin's disease. American College of Radiology. ACR Appropriateness Criteria.
Wolkov, H. B., Elman, A. J., Hoppe, R. T., Pistenmaa, D. A., Mauch, P. M., Constine, L. S., Deming, R. L., Dosoretz, D. E., Prosnitz, L. R., Yahalom, J., Chauvenet, A....> ;Radiology. 2000 Jun
Utilization of mustard waste isolates for improved production of astaxanthin by Xanthophyllomyces dendrorhous.
Tinoi, J., Rakariyatham, N., Deming, R. L.> ;J Ind Microbiol Biotechnol. 2006 Apr
Join now to see all

Press Mentions

Iowans Honored for Work in Cancer Control at Annual Iowa Cancer SummitNovember 1st, 2022
New Cancer Center Opens at MercyOne HospitalJanuary 22nd, 2022
New Book Provides Dose of InspirationMay 8th, 2020
Join now to see all